Mostrar el registro sencillo del ítem

dc.contributor.authorLópez-Muñoz, F.
dc.contributor.authorSanz-Fuentenebro, Javier
dc.contributor.authorRubio, G.
dc.contributor.authorGarcía-García, P.
dc.contributor.authorÁlamo González, C
dc.date.accessioned2018-07-09T12:36:08Z
dc.date.available2018-07-09T12:36:08Z
dc.date.issued2015-09
dc.identifier.citationLópez-Muñoz, F., Sanz-Fuentenebro, J., Rubio, G., García-García, P., & Álamo, C. (2015). Quo Vadis Clozapine? A Bibliometric Study of 45 Years of Research in International Context. International Journal of Molecular Sciences, 16(9), 23012–23034. http://doi.org/10.3390/ijms160923012es
dc.identifier.issn1422-0067
dc.identifier.urihttp://hdl.handle.net/20.500.12020/779
dc.description.abstractWe have carried out a bibliometric study about the international scientific publications on clozapine. We have used the EMBASE and MEDLINE databases, and we applied bibliometric indicators of production, as Price’s Law on the increase of scientific literature. We also calculated the participation index (PI) of the different countries. The bibliometric data have also been correlated with some social and health data from the 12 most productive countries in biomedicine and health sciences. In addition, 5607 original documents dealing with clozapine, published between 1970 and 2013, were downloaded. Our results state non-fulfilment of Price’s Law, with scientific production on clozapine showing linear growth (r = 0.8691, vs. r = 0.8478 after exponential adjustment). Seven of the 12 journals with the highest numbers of publications on clozapine have an Impact Factor > 2. Among the countries generating clozapine research, the most prominent is the USA (PI = 24.32), followed by the UK (PI = 6.27) and Germany (PI = 5.40). The differences among countries on clozapine research are significantly related to economic variables linked to research. The scientific interest in clozapine remains remarkable, although after the application of bibliometric indicators of production, a saturation point is evident in the growth of scientific literature on this topic.es
dc.language.isoenes
dc.publisherMDPI: Open Acess Journales
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleQuo Vadis Clozapine? A Bibliometric Study of 45 Years of Research in International Contextes
dc.typearticlees
dc.identifier.doi10.3390/ijms160923012
dc.issue.number9es
dc.journal.titleInternational Journal of Molecular Scienceses
dc.page.initial23012es
dc.page.final23034es
dc.rights.accessRightsopenAccesses
dc.subject.areaPsicologíaes
dc.subject.keywordClozapinees
dc.subject.keywordAtypical antipsychoticses
dc.subject.keywordSecond-generation antipsychoticses
dc.subject.keywordBibliometryes
dc.subject.keywordSchizophreniaes
dc.subject.unesco3201.05 Psicología Clínicaes
dc.volume.number16es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional